Erik W Anderson

7PUBLICATIONS
4CO-AUTHORS
Medical physiology not elsewhere classifiedCellular nervous systemMedical infection agents (incl. prions)Other education not elsewhere classifiedSolid state chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 25, 2024
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.

Erik W Anderson, Marissa Sansone, Bhakti Shah

|Nov 17, 2022
Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.

Erik W Anderson, Ying Jin, Andrew Shih

|Jun 09, 2022
Determination of the minimal clinically important difference (MCID) of the physician global assessment (PGA) in SLE.

Erik W Anderson, Meggan Mackay, Giovanni Franchin

|May 13, 2022
Reply.

Erik W Anderson, Lara El Khoury, Julie S Schwartzman-Morris

|Oct 23, 2021
Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus.

Erik W Anderson, Joanna Fishbein, Joseph Hong

|Apr 03, 2020
Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations.

Erik Anderson, Richard Furie

Pageof 2

Frequent Collaborators

3 joint publications

Betty Diamond

3 joint publications

Cynthia Aranow

2 joint publications

Richard A Furie

1 joint publications

Giovanni Franchin